fda statement bpc-157 not approved fda.gov The is moving to make research-only peptides easier to obtain, despite warnings from former officials that the move could undermine the drug approval process FDA advisers back BPC-157 and

The rationale was that these unregulated products pose severe health risks, including potential contamination with mould or bacteria, dosing errors, and life-threatening adverse reactions. The crackdown aligns with the implementation of New Zealands Medicines Amendment Act 2025 , which introduced a fast-track consent by verification pathway for legitimate pharmaceuticals

Or more precisely, nothing was ever made public

But youre also not trying to live like a monk

In a recent episode of the Modern Wisdom Podcast , Dr

Tidal wave of future problems Its impossible to expect there to be no mental or physical health casualties among those with B12 deficiency if the only provision for them is a tablet that wont work to heal nerves or reduce symptoms but will raise serum levels